Stay updated with breaking news from Nima Farzan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Received FDA clearance of IND application for brain-penetrant MEK inhibitor, KIN-7136; expect to enter the clinic with Phase 1 trial in the second half of 2023Cash, cash equivalents and investments of...
First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a... | April 17, 2023
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture May 13, 2021 16:02 ET | Source: Kinnate Biopharma Kinnate Biopharma Financing led by OrbiMed Asia Partners, with participation from OrbiMed Private Investments and Foresite Capital The joint venture will have exclusive license to develop and commercialize Kinnate’s currently most advanced kinase inhibitor candidates in Greater China Veteran biopharmaceutical industry executive Wenn Sun, Ph.D. has been named as Executive Chair SAN FRANCISCO and SAN DIEGO, May 13, 2021 ...